Company Encyclopedia
View More
name
Star Lake Science
600866.SH
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroying Hepatitis B virus DNA; and L-threonine that is used in premixtures, and pig and poultry feed. It also provides disodium 5’-ribonucleotide to cure chronic hepatitis, muscular atrophy, and eye diseases; disodium 5-inosinate to cure leukopenia, thrombocytopenia, and chronic and acute hepatitis; and inosine, which is used for the treatment of chronic and acute hepatitis, heart disease, leukopenia or thrombocytopenia, central choroidoretinitis, etc. In addition, the company offers disodium 5’-guanylate for canned and salted meat, ham, etc.
2.092 T
600866.SHMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Packaged Foods and MeatsIndustry
Industry Ranking66/137
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE16.08%A
    • Profit Margin7.71%B
    • Gross Margin15.92%D
  • Growth ScoreC
    • Revenue YoY-4.66%D
    • Net Profit YoY47.97%B
    • Total Assets YoY20.69%A
    • Net Assets YoY9.45%B
  • Cash ScoreC
    • Cash Flow Margin1297.53%B
    • OCF YoY-4.66%D
  • Operating ScoreA
    • Turnover1.05A
  • Debt ScoreC
    • Gearing Ratio50.79%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Star Lake Science: The net profit for the third quarter was 179 million yuan, a year-on-year increase of 4.56%

    Star Lake Science announced that its revenue for the third quarter was 3.918 billion yuan, a year-on-year decrease of 8.96%; net profit was 179 million yuan, a year-on-year increase of 4.56%. Revenue for the first three quarters was 12.077 billion yuan, a year-on-year decrease of 5.57%; net profit was 1.015 billion yuan, a year-on-year increase of 49.90%

    Zhitong·
    SH
    600866
    +0.44%
    Zhitong·
    SH
    600866
    +0.44%

    Star Lake Science: Shareholders holding more than 5%, Tie Xiaorong and his concerted actors collectively reduced their holdings by 19.12 million shares

    Star Lake Science announced that shareholder Tie Xiaorong and his concerted parties collectively reduced their holdings by 19.12 million shares on October 23, 2025, decreasing their shareholding ratio from 12.76% to 11.61%. Tie Xiaorong's shareholding ratio fell from 2.37% to 1.21%, while Ningxia Yipin Investment Group Co., Ltd. maintained its shareholding ratio. This reduction does not trigger a tender offer and does not affect the company's controlling shareholder and actual controller

    Zhitong·
    SH
    600866
    +0.44%
    Zhitong·
    SH
    600866
    +0.44%

    Star Lake Science adjusts corn futures hedging transactions and increases options contracts

    Star Lake Science approved the proposal to adjust corn futures hedging transactions at the 13th meeting of the 11th Board of Directors, increasing trading of on-exchange and off-exchange corn options contracts. The trading period is until April 19, 2026, with a maximum margin requirement of 50 million yuan and a maximum contract value of 500 million yuan, funded by its own capital. This move aims to control raw material price risks but still faces market and liquidity risks, and corresponding risk control measures have been established

    Zhitong·
    SH
    600866
    +0.44%
    Zhitong·
    SH
    600866
    +0.44%

    Star Lake Science: Net profit of 836 million yuan in the first half of 2025, a year-on-year increase of 65.22%

    Star Lake Science announced that in the first half of 2025, operating revenue was 8.16 billion yuan, a year-on-year decrease of 3.85%. Net profit was 836 million yuan, a year-on-year increase of 65.22%

    Zhitong·
    SH
    600866
    +0.44%
    Zhitong·
    SH
    600866
    +0.44%

    Star Lake Science plans to invest no more than 3.3 billion yuan to construct a 450,000-ton amino acid and supporting engineering project

    Star Lake Science plans to invest no more than 3.3 billion yuan to construct a 450,000-ton amino acid and supporting engineering project, aimed at optimizing business structure and enhancing production scale. The project is expected to have a construction period of 22 months, with an estimated annual sales revenue of about 3.9 billion yuan and a gross profit margin of approximately 10% after reaching production capacity. This project will strengthen the company's competitiveness in the fields of animal nutrition, food additives, and seasonings, aligning with the company's strategic development plan

    Zhitong·
    SH
    600866
    +0.44%
    Zhitong·
    SH
    600866
    +0.44%
    © 2025 Longbridge｜Disclaimer